Navigation Links
Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies

Quick glance at the latest new drugs. Pharma Opinions unveils a new site were top notch biotech companies will see their new approved products reviewed and commented.

Costa de Caparica, Portugal (PRWEB) October 21, 2008 -- A new blog review on the most recent approved drugs mainly in the U.S. Pharma Opinions unveils a new site were top notch biotech companies will see their new, approved products reviewed and commented on.

Breakthrough drugs and pharmaceutical companies are reviewed each time an approval is issued by FDA. The site extracts all the 'juicy' information from the companies Press Releases and puts it 'plain and simple' for the general opinion to understand the 'facts and figures' of the reason for the drug to be approved, and why it is such a breakthrough.

There will be also interviews with CEOs and officers of the pharmaceutical companies.

Among the most recent reviewed companies are Generex, Biovail and Cephalon

The blog is owned by Bruno Miguel Espalha, a portuguese 27 year old Pharmacist.

You can find the site at


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
2. Amylin Pharmaceuticals Reports Third Quarter Financial Results
3. New Pharmaceutical Company to Target Alzheimers Disease
4. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
5. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
6. China Pharma Holdings, Inc. Appoints The Ruth Group
7. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
8. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
9. Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME)
10. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
11. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson ... clinical data solutions business. , Jeff Parr has spent the past decade providing quality ... Dennison, Thermo Fisher, and Ab Sciex to name a few. He is based ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... educational opportunities for school age children in the areas of Science, Technology, Engineering ... sectors of the national economy, and the program aims to increase the number ...
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader in products and services ... 600 compact clean steam generator . This unit is a skid mounted system ... HTM2010, and EN285 standards. The CMS-C 600 generator can produce up to a ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. today ... has designated its lead Microbiota Restoration Therapy (MRT) ... of recurrent Clostridium difficile (C diff) ... that causes 29,000 deaths in the U.S. annually. ... company that was founded to revolutionize the treatment ...
Breaking Biology Technology:
(Date:10/9/2015)... ) ... "Samsung Galaxy S6 Fingerprint Sensor - Reverse ... --> ) has announced ... S6 Fingerprint Sensor - Reverse Costing Analysis" ... Research and Markets ( ) ...
(Date:10/8/2015)... 8, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet announces that revenues for the three ... compared with $113,00 for the three months ended ... ended September 30, 2015 were approximately $520,000. ...
(Date:10/6/2015)... CITY , Oct. 6, 2015 Track ... announced today that it has signed a contract with ... services across the full range of sentences under the ... President of the Americas. "This contract with the Virginia ... of the US and advances our position as a ...
Breaking Biology News(10 mins):